To hear about similar clinical trials, please enter your email below
Trial Title:
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
NCT ID:
NCT01311037
Condition:
Advanced Breast Cancer
Conditions: Official terms:
Breast Neoplasms
Aromatase Inhibitors
Conditions: Keywords:
Premenopausal Women with Advanced Breast Cancer
Study type:
Observational
Overall status:
Unknown status
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
GnRh Analogue and Aromatase Inhibitor
Description:
GnRh Analogue and Aromatase Inhibitor
Summary:
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive
Premenopausal Women with Advanced Breast Cancer A Prospective Trial.
Detailed description:
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive
Premenopausal Women with Advanced Breast Cancer A Prospective Trial.
Criteria for eligibility:
Study pop:
Receptor Positive Premenopausal Women with Advanced Breast Cancer.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Receptor Positive Premenopausal Women with Advanced Breast Cancer.
Exclusion Criteria:
- Any woman other than diagnosis of Receptor Positive Premenopausal with Advanced
Breast Cancer.
Gender:
Female
Minimum age:
45 Years
Maximum age:
85 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Kfsh & Rc
Address:
City:
Riyadh
Country:
Saudi Arabia
Status:
Recruiting
Start date:
January 2009
Lead sponsor:
Agency:
King Faisal Specialist Hospital & Research Center
Agency class:
Other
Source:
King Faisal Specialist Hospital & Research Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT01311037
